Cargando…

Moxibustion Protects Dopaminergic Neurons in Parkinson's Disease through Antiferroptosis

Ferroptosis is associated with neural degeneration of dopaminergic neurons in Parkinson's disease (PD). However, how to control the level of ferroptosis in PD remains unclear. Clinically, moxibustion has been used to treat PD and has an apparent therapeutic effect on improving the motor symptom...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Zifeng, Si, Wenwen, Li, Xinrong, Ye, Shanyu, Liu, Xuelei, Ji, Yichun, Hao, Xiaoqian, Chen, Dongfeng, Zhu, Meiling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8191581/ https://www.ncbi.nlm.nih.gov/pubmed/34122606 http://dx.doi.org/10.1155/2021/6668249

Ejemplares similares

Moxibustion Exerts a Neuroprotective Effect through Antiferroptosis in Parkinson's Disease
por: Lu, Juan, et al.
Publicado: (2019)

miR-335 promotes ferroptosis by targeting ferritin heavy chain 1 in in vivo and in vitro models of Parkinson's disease
por: Li, Xinrong, et al.
Publicado: (2021)

RNA Binding Protein Motif 3 Inhibits Oxygen-Glucose Deprivation/Reoxygenation-Induced Apoptosis Through Promoting Stress Granules Formation in PC12 Cells and Rat Primary Cortical Neurons
por: Si, Wenwen, et al.
Publicado: (2020)

Experimental Models of Cognitive Impairment for Use in Parkinson’s Disease Research: The Distance Between Reality and Ideal
por: Fan, Yaohua, et al.
Publicado: (2021)

Corrigendum: Experimental Models of Cognitive Impairment for Use in Parkinson's Disease Research: The Distance Between Reality and Ideal
por: Fan, Yaohua, et al.
Publicado: (2021)

Parkinson’s Disease Dementia: Synergistic Effects of Alpha-Synuclein, Tau, Beta-Amyloid, and Iron
por: Han, Jiajun, et al.
Publicado: (2021)

Moxibustion treatment for Parkinson’s disease: study protocol for a randomized controlled trial
por: Wu, Chunxiao, et al.
Publicado: (2023)

In situ analysis of acupuncture protecting dopaminergic neurons from lipid peroxidative damage in mice of Parkinson's disease
por: Zuo, Tingting, et al.
Publicado: (2022)

Parkinson's disease and dopaminergic neurons
Publicado: (2012)

Sorting Nexin 5 Plays an Important Role in Promoting Ferroptosis in Parkinson's Disease
por: Huang, Zifeng, et al.
Publicado: (2022)

Parkinson’s Disease, the Dopaminergic Neuron and Gammahydroxybutyrate
por: Mamelak, Mortimer
Publicado: (2018)

Methyltransferase 3 Mediated miRNA m6A Methylation Promotes Stress Granule Formation in the Early Stage of Acute Ischemic Stroke
por: Si, Wenwen, et al.
Publicado: (2020)

Smilagenin Protects Dopaminergic Neurons in Chronic MPTP/Probenecid—Lesioned Parkinson’s Disease Models
por: He, Xuan, et al.
Publicado: (2019)

CLR01 protects dopaminergic neurons in vitro and in mouse models of Parkinson’s disease
por: Bengoa-Vergniory, Nora, et al.
Publicado: (2020)

Irisin protects the substantia nigra dopaminergic neurons in the rat model of Parkinson’s disease
por: Zarbakhsh, Sam, et al.
Publicado: (2019)

Src Inhibition Attenuates Neuroinflammation and Protects Dopaminergic Neurons in Parkinson’s Disease Models
por: Yang, Hanyu, et al.
Publicado: (2020)

Vulnerability of Mesostriatal Dopaminergic Neurons in Parkinson's Disease
por: González-Hernández, Tomás, et al.
Publicado: (2010)

Gastrodin Protects Apoptotic Dopaminergic Neurons in a Toxin-Induced Parkinson's Disease Model
por: Kumar, Hemant, et al.
Publicado: (2013)

Progranulin Gene Delivery Protects Dopaminergic Neurons in a Mouse Model of Parkinson’s Disease
por: Van Kampen, Jackalina M., et al.
Publicado: (2014)

Necrostatin-1 protection of dopaminergic neurons
por: Wu, Jing-ru, et al.
Publicado: (2015)

Quercetin Protects against MPP(+)/MPTP-Induced Dopaminergic Neuron Death in Parkinson's Disease by Inhibiting Ferroptosis
por: Lin, Zhi-Hao, et al.
Publicado: (2022)

Roles of FGF20 in dopaminergic neurons and Parkinson's disease
por: Itoh, Nobuyuki, et al.
Publicado: (2013)

Fucoidan Protects Dopaminergic Neurons by Enhancing the Mitochondrial Function in a Rotenone-induced Rat Model of Parkinson’s Disease
por: Zhang, Li, et al.
Publicado: (2018)

Selenoprotein T Exerts an Essential Oxidoreductase Activity That Protects Dopaminergic Neurons in Mouse Models of Parkinson's Disease
por: Boukhzar, Loubna, et al.
Publicado: (2016)

No synergism between bis(propyl)-cognitin and rasagiline on protecting dopaminergic neurons in Parkinson's disease mice
por: Zheng, Cheng-you, et al.
Publicado: (2016)

Pharmacological Inhibition of Necroptosis Protects from Dopaminergic Neuronal Cell Death in Parkinson’s Disease Models
por: Iannielli, Angelo, et al.
Publicado: (2018)

Ketamine Does Not Exert Protective Properties on Dopaminergic Neurons in the Lactacystin Mouse Model of Parkinson’s Disease
por: Deneyer, Lauren, et al.
Publicado: (2018)

Gastrodin protects dopaminergic neurons via insulin-like pathway in a Parkinson’s disease model
por: Yan, Jinyuan, et al.
Publicado: (2019)

BMP5/7 protect dopaminergic neurons in an α-synuclein mouse model of Parkinson’s disease
por: Vitic, Zagorka, et al.
Publicado: (2020)

ATP13A2 protects dopaminergic neurons in Parkinson's disease: from biology to pathology
por: Dang, Tao, et al.
Publicado: (2022)

Knockout or inhibition of USP30 protects dopaminergic neurons in a Parkinson’s disease mouse model
por: Fang, Tracy-Shi Zhang, et al.
Publicado: (2023)

Triggering Receptor Expressed on Myeloid Cells 2 Protects Dopaminergic Neurons by Promoting Autophagy in the Inflammatory Pathogenesis of Parkinson’s Disease
por: Huang, Wei, et al.
Publicado: (2021)

Pretreatment with Roxadustat (FG-4592) Attenuates Folic Acid-Induced Kidney Injury through Antiferroptosis via Akt/GSK-3β/Nrf2 Pathway
por: Li, Xue, et al.
Publicado: (2020)

Dopaminergic Neuronal Imaging in Genetic Parkinson's Disease: Insights into Pathogenesis
por: McNeill, Alisdair, et al.
Publicado: (2013)

Degeneration of Dopaminergic Neurons Due to Metabolic Alterations and Parkinson’s Disease
por: Song, Juhyun, et al.
Publicado: (2016)

Induced dopaminergic neurons: A new promise for Parkinson’s disease
por: Xu, Zhimin, et al.
Publicado: (2017)

Sodium Phenylbutyrate Controls Neuroinflammatory and Antioxidant Activities and Protects Dopaminergic Neurons in Mouse Models of Parkinson’s Disease
por: Roy, Avik, et al.
Publicado: (2012)

The c-Abl inhibitor, Nilotinib, protects dopaminergic neurons in a preclinical animal model of Parkinson's disease
por: Karuppagounder, Senthilkumar S., et al.
Publicado: (2014)

Cicadidae Periostracum, the Cast-Off Skin of Cicada, Protects Dopaminergic Neurons in a Model of Parkinson's Disease
por: Lim, Hye-Sun, et al.
Publicado: (2019)

Inhibition of repulsive guidance molecule-a protects dopaminergic neurons in a mouse model of Parkinson’s disease
por: Oda, Wakana, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9e2r7fdfptmi80gft1srv4ful4